Related Experiment Video
Updated: Aug 14, 2025

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
Published on: October 27, 2023
Purpura Fulminans and Spotted Fever: A Case Series from South India
Karthik Gunasekaran1, Divyaa Elangovan2, Susmitha Perumalla2
1Department of Internal Medicine, Christian Medical College, Vellore, Tamil Nadu, India.
Abstract:
Purpura fulminans (PF) is associated with acute infections such as meningococcal, staphylococcal, streptococcal, and rickettsial infections. However, there are only a few reports of association of PF with rickettsial fever from India. In this case series of seven adults with PF, four were definitive cases of spotted fever as the ompA real-time polymerase chain reaction was positive. The other three adults were probable cases of spotted fever, as they were positive by immunoglobulin M enzyme-linked immunosorbent assay, and their fever subsided within 72 h of rickettsia-specific therapy. Three of the seven patients had peripheral gangrene. These patients, despite presenting with severe spotted fever, had a favorable outcome. This is attributed to the high index of suspicion and early treatment supported by diagnostic assays.
Insights
Purpura fulminans (PF) in India is rarely linked to rickettsial infections. This case series shows early diagnosis and treatment of spotted fever can lead to favorable outcomes, even with severe symptoms like gangrene.
Area of Science:
- Infectious Diseases
- Microbiology
- Dermatology
Background:
- Purpura fulminans (PF) is a rare, severe thrombotic disorder often associated with infections.
- Rickettsial infections, particularly spotted fevers, are increasingly recognized globally but underreported in India concerning PF.
- Early recognition and management are crucial for favorable outcomes in severe infectious diseases.
Observation:
- This case series describes seven adult patients in India presenting with Purpura fulminans.
- Four patients were diagnosed with definitive spotted fever via ompA real-time PCR.
- Three patients had probable spotted fever, confirmed by IgM ELISA and rapid clinical response to antibiotics.
Findings:
- Three out of seven patients developed peripheral gangrene, a severe complication of Purpura fulminans.
- All seven patients with Purpura fulminans associated with spotted fever experienced a favorable outcome.
- Early initiation of rickettsia-specific therapy, supported by diagnostic assays, was key to recovery.
Implications:
- Highlights the importance of considering rickettsial infections in Purpura fulminans cases in India.
- Emphasizes the efficacy of prompt diagnosis and targeted antibiotic treatment for severe spotted fever.
- Suggests that a high index of suspicion and rapid diagnostic support can improve prognosis in Purpura fulminans.
More Related Videos
10:50Detection and Quantification of Plasmodium falciparum in Aqueous Red Blood Cells by Attenuated Total Reflection Infrared Spectroscopy and Multivariate Data Analysis
Published on: November 2, 2018
05:20Separation of Plasmodium falciparum Late Stage-infected Erythrocytes by Magnetic Means
Published on: March 2, 2013
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Patterns of Fever
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Myocarditis II: Clinical Features and Diagnostic Tests
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...